|1.||Herzog, Christian: 3 articles (05/2011 - 12/2006)|
|2.||Bovier, Patrick A: 2 articles (10/2008 - 08/2008)|
|3.||Hatz, Christoph: 1 article (05/2011)|
|4.||van der Ploeg, Robert: 1 article (05/2011)|
|5.||Frösner, Gert: 1 article (05/2011)|
|6.||Hunt, Marjory: 1 article (05/2011)|
|7.||Beck, Bernhard R: 1 article (05/2011)|
|8.||Abu-Abed, Jaber: 1 article (09/2007)|
|9.||Ashkenazi, Shai: 1 article (09/2007)|
|10.||Dagan, Ron: 1 article (09/2007)|
|1.||Hepatitis A (Hepatitis, Infectious)
10/01/2008 - "Epaxal: a virosomal vaccine to prevent hepatitis A infection."
01/01/2002 - "Nasalflu is based on the virosomal concept which is registered in the EU as Epaxal Berna, a vaccine against Hepatitis A, and Inflexal Berna V, a subunit influenza vaccine. "
08/01/1993 - "The inactivated hepatitis A vaccine Epaxal Berna and the hepatitis A immunoglobulin preparation Globuman were products of the Swiss Serum and Vaccine Institute. "
05/01/2011 - "Boosting adult travelers with the virosome-formulated, aluminum-free hepatitis A vaccine Epaxal up to 128 months after a single primary dose confers full protection against hepatitis A, even in travelers aged 50 years and above. "
09/01/2007 - "Healthy children 12- to 15-month-old were randomized to receive either a pediatric dose (0.25 mL) of Epaxal coadministered with DTPaHibIPV, oral polio vaccine, and measles-mumps-rubella vaccine (n = 109; group A), or Epaxal given alone (n = 105; group B), or Havrix Junior coadministered with DTPaHibIPV, oral polio vaccine, and measles-mumps-rubella vaccine (n = 108; group C). "
|5.||Human Influenza (Influenza)
|1.||Hepatitis A Vaccines (Hepatitis A Vaccine)
|4.||Measles-Mumps-Rubella Vaccine (MMR Vaccine)
|5.||Influenza Vaccines (FluMist)